Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,429 | 932 | 99.6% |
| Education | $53.30 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,220 | 105 | $0 (2024) |
| Novo Nordisk Inc | $1,699 | 178 | $0 (2024) |
| Lilly USA, LLC | $1,543 | 96 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,255 | 86 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $929.05 | 54 | $0 (2024) |
| PFIZER INC. | $844.57 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $616.37 | 39 | $0 (2022) |
| Abbott Laboratories | $615.08 | 43 | $0 (2024) |
| Amgen Inc. | $550.75 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $536.54 | 37 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,941 | 108 | AstraZeneca Pharmaceuticals LP ($442.90) |
| 2023 | $1,702 | 102 | Novo Nordisk Inc ($359.87) |
| 2022 | $2,098 | 115 | GlaxoSmithKline, LLC. ($315.90) |
| 2021 | $1,868 | 131 | Davol Inc. ($166.82) |
| 2020 | $898.47 | 68 | Novo Nordisk Inc ($189.51) |
| 2019 | $1,680 | 125 | Lilly USA, LLC ($284.56) |
| 2018 | $2,218 | 150 | AstraZeneca Pharmaceuticals LP ($403.43) |
| 2017 | $2,076 | 139 | AstraZeneca Pharmaceuticals LP ($342.99) |
All Payment Transactions
938 individual payment records from CMS Open Payments — Page 36 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/06/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: Diabetes | ||||||
| 06/26/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: VACCINES | ||||||
| 06/23/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: DIABETES | ||||||
| 06/19/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Obesity | ||||||
| 06/16/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Endocrinology | ||||||
| 06/15/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Respiratory | ||||||
| 05/19/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/19/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/19/2017 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | Cash or cash equivalent | $13.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/18/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 05/12/2017 | PFIZER INC. | VIAGRA (Drug), ELIQUIS, CHANTIX | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 05/11/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug), BUTRANS | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/05/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 05/05/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $5.35 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2017 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Diabetes | ||||||
| 04/28/2017 | Lilly USA, LLC | HUMALOG (Drug), TRADJENTA, TRULICITY | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Diabetes | ||||||
| 04/27/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Respiratory | ||||||
| 04/20/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/17/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: DIABETES | ||||||
| 04/14/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Opioid Induced Constipation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,372 | 2,733 | $288,078 | $160,390 |
| 2022 | 25 | 1,449 | 2,781 | $291,450 | $165,570 |
| 2021 | 26 | 1,550 | 2,857 | $275,810 | $160,349 |
| 2020 | 29 | 1,771 | 2,863 | $241,376 | $126,522 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 1,032 | $154,800 | $87,597 | 56.6% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 42 | 333 | $58,207 | $33,285 | 57.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $12,425 | $9,209 | 74.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 79 | 79 | $7,150 | $5,682 | 79.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 104 | $13,000 | $5,015 | 38.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 101 | 134 | $8,040 | $2,997 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 89 | $3,130 | $2,694 | 86.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $3,300 | $2,439 | 73.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 35 | 54 | $4,320 | $2,211 | 51.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 32 | 36 | $3,600 | $1,246 | 34.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 67 | 67 | $2,680 | $1,232 | 46.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 66 | 66 | $2,640 | $1,214 | 46.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 82 | 102 | $4,080 | $1,003 | 24.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 82 | $1,640 | $776.15 | 47.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 74 | $1,480 | $621.60 | 42.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 66 | 175 | $1,050 | $560.93 | 53.4% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 16 | 21 | $1,050 | $529.90 | 50.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 12 | 13 | $975.00 | $450.84 | 46.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 13 | $897.00 | $389.90 | 43.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 12 | 15 | $900.00 | $333.72 | 37.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 34 | $1,190 | $293.23 | 24.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 53 | 74 | $444.00 | $252.34 | 56.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 14 | 16 | $320.00 | $151.00 | 47.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 18 | 20 | $400.00 | $113.20 | 28.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 18 | $360.00 | $91.44 | 25.4% |
About Dr. Jeffrey Kraft, DO
Dr. Jeffrey Kraft, DO is a Family Medicine healthcare provider based in Warren, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346221785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Kraft, DO has received a total of $14,482 in payments from pharmaceutical and medical device companies, with $1,941 received in 2024. These payments were reported across 938 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($14,429).
As a Medicare-enrolled provider, Kraft has provided services to 6,142 Medicare beneficiaries, totaling 11,234 services with total Medicare billing of $612,831. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Warren, MI
- Active Since 11/11/2005
- Last Updated 08/16/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346221785
Products in Payments
- FARXIGA (Drug) $1,082
- TRULICITY (Drug) $875.18
- Ozempic (Drug) $822.94
- TRELEGY ELLIPTA (Drug) $791.92
- XARELTO (Drug) $499.24
- BREZTRI (Drug) $492.77
- JARDIANCE (Drug) $394.24
- Vascepa (Drug) $359.85
- ENTRESTO (Drug) $319.09
- VRAYLAR (Drug) $317.26
- CHANTIX (Drug) $307.70
- Rybelsus (Drug) $270.06
- AIRSUPRA (Drug) $260.21
- FREESTYLE LIBRE 3 (Device) $244.07
- Truvada (Drug) $238.14
- Victoza (Drug) $227.74
- XIFAXAN (Drug) $226.28
- SYMBICORT (Drug) $224.58
- Kerendia (Drug) $213.51
- STIOLTO RESPIMAT (Drug) $213.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warren
Ping Wang, Md, MD
Family Medicine — Payments: $127,206
Dr. Jason Rupeka, Do, DO
Family Medicine — Payments: $65,540
Dr. Jacob Bair, D.o, D.O
Family Medicine — Payments: $33,701
Saroj Misra, Do, DO
Family Medicine — Payments: $29,024
Dr. Kevin Agrest, Do, DO
Family Medicine — Payments: $14,748
Dr. Kimberly Jackson, D.o, D.O
Family Medicine — Payments: $11,737